A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb ...

First clinical data for INCA033989, a novel monoclonal antibody from Incyte (Nasdaq: INCY) targeting CALR-mutant ...

Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension ...

Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

Following the 18th European Hematology Association Congress, pharmaphorum's Hannah Blake spoke with hematology expert, Dr Moshe Talpaz, to find out more about the research and development ...

will be presented at the European Hematology Association (EHA) 2025 Hybrid Congress, taking place June 12-15, 2025, in Milan, Italy and online. The presentation will highlight initial results from ...

today announced that the European Hematology Association ("EHA") has accepted Telo Genomics' abstract submission for a poster presentation during the upcoming EHA 2025 Congress. The new abstract ...